AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
NEW DELHI, Aug 2 Asia Pulse - Ranbaxy Laboratories (BSE:RANB) has initiated the process to file its Anti Retro Viral (ARV) products with the US Food and Drug Administration (USFDA) with first filing likely before this year end.
The filing would take place under the expedited review process of the USFDA for the US ...